CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
argenx SE Company Snapshot
argenx SE operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other miscellaneous service companies in Europe: Redx Pharma PLC of the United Kingdom (2017 sales of £30.47 million [US$38.04 million] ), MDxHealth S.A. (35.56 million Euro [US$40.23 million] of which 100% was Diagnostic Tools), and Innate Pharma S.A. which is based in France (32.63 million Euro [US$36.91 million] of which 100% was Licensing Revenue).

Sales Analysis. argenx SE reported sales of 36.42 million Euro (US$41.19 million) for the year ending December of 2017. This represents an increase of 147.5% versus 2016, when the company's sales were 14.71 million Euro. Sales at argenx SE have increased during each of the previous five years (and since 2012, sales have increased a total of 2,106%). Sales of Milestone Payments saw an increase that was more than double the company's growth rate: sales were up 1,835.4% in 2017, from 500,000.00 Euro to 9.68 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
argenx SE
  Stock Performance Chart for argenx SE
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 89.60
(Figures in Euro)
1 Week 4.3%   13 Weeks 4.6%  
4 Weeks 15.3%   52 Weeks 255.6%  
 
argenx SE Key Data:
  Ticker: ARGX Country: Netherlands
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 36,415,000
(Year Ending Jan 2018).
Employees: 73
  Currency: Euro Market Cap: 2,907,589,440
  Fiscal Yr Ends: December Shares Outstanding: 32,450,775
  Share Type: Actions Ordinaires Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.